Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639148 | 0.87 | SLC6A3 (0.67) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL29011848 | 0.86 | GAA (0.60) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL31318316 | 0.86 | SLC6A3 (0.78) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL30045516 | 0.86 | GAA (0.60) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL27843639 | 0.85 | SLC6A3 (0.74) | SLC6A3SLC6A4KDM4ESLC6A2POLB | |
| SCHEMBL1775832 | 0.85 | SLC6A3 (0.74) | SLC6A3SLC6A4KDM4ESLC6A2POLB | |
| SCHEMBL20200106 | 0.85 | KDM4E (0.60) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL269580 | 0.84 | SMN1; SMN2 (0.70) | KDM4ECYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL1515687 | 0.84 | GAA (0.63) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL8923988 | 0.84 | SLC6A3 (0.73) | SLC6A3SLC6A4KDM4ECYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311813-B | Palladium-catalyzed meta-C-H functionalized universal ligands | 斯克利普斯研究院 | 2023-02-28 | — | — | CN | disclosed |
| EP-1387614-B1 | PROCESS FOR PREPARING PURIFIED SHILAJIT COMPOSITION FROM NATIVE SHILAJIT | NATREON INC (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-1387614-A4 | PROCESS FOR PREPARING PURIFIED SHILAJIT COMPOSITION FROM NATIVE SHILAJIT | NATREON INC (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-1435982-A1 | DELIVERY SYSTEM FOR PHARMACEUTICAL, NUTRITIONAL AND COSMETIC INGREDIENTS | Natreon Inc. (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1387614-A2 | PROCESS FOR PREPARING PURIFIED SHILAJIT COMPOSITION FROM NATIVE SHILAJIT | Natreon Inc. (US) | 2004-02-11 | — | — | EP | disclosed |
| WO-2003035094-A1 | DELIVERY SYSTEM FOR PHARMACEUTICAL, NUTRITIONAL AND COSMETIC INGREDIENTS | NATREON INC. (US) | 2003-05-01 | — | — | WO | disclosed |
| US-20030039662-A1 | Process for preparing purified shilajit composition from native shilajit | GHOSAL SHIBNATH (IN) | 2003-02-27 | — | — | US | disclosed |
| WO-2002094984-A2 | PROCESS FOR PREPARING PURIFIED SHILAJIT COMPOSITION FROM NATIVE SHILAJIT | NATREON INC. (US) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030039662-A1 | Process for preparing purified shilajit composition from native shilajit | Q6ZSR9, CYP26B1, CYP26A1 | SLC6A3 4097/4885SLC6A4 3926/4885KDM4E 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.